In the last 12 months, insiders at Cartesian Therapeutics, Inc. ($RNAC) filed 386 transactions with the SEC: 53 open-market purchases totaling $17,234,195 and 50 sales totaling $5,169,207. Net insider sentiment: net buying.
Cartesian Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- SPRINGER TIMOTHY A (Director) — 87 transactions totaling $126,749,993
- Kurtoglu Metin (Chief Technology Officer) — 38 transactions totaling $2,703,948
- Brunn Carsten (President and CEO) — 29 transactions totaling $1,574,969
- Jewell Christopher M (Chief Scientific Officer) — 20 transactions totaling $1,160,446
- Miljkovic Milos (Chief Medical Officer) — 18 transactions totaling $1,141,091
View all SEC Filings for Cartesian Therapeutics, Inc. (RNAC).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Singer Michael | Director | G | Common Stock | 6555 | $0.00 | 704,446.0000 | 26,003,606 | 0.92% | 0.03% |
| Jan. 6, 2026 | Davis Blaine | Chief Financial Officer | S | Common Stock | 10591 | $6.82 | 121,220.0000 | 26,003,606 | 8.03% | 0.04% |
| Jan. 6, 2026 | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 3573 | $6.82 | 58,820.0000 | 26,003,606 | 5.73% | 0.01% |
| Jan. 6, 2026 | Brunn Carsten | President and CEO | S | Common Stock | 23766 | $6.82 | 323,530.0000 | 26,003,606 | 6.84% | 0.09% |
| Jan. 2, 2026 | SPRINGER TIMOTHY A | Director | A | Common Stock | 2600 | $0.00 | 9,633,493.0000 | 26,003,606 | 0.03% | 0.01% |
| Jan. 2, 2026 | DeSilva Nishan M | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2026 | DeSilva Nishan M | Director | A | Common Stock | 2600 | $0.00 | 11,366.0000 | 26,003,606 | 29.66% | 0.01% |
| Jan. 2, 2026 | Brunn Carsten | President and CEO | A | Common Stock | 143200 | $0.00 | 347,296.0000 | 26,003,606 | 70.16% | 0.55% |
| Jan. 2, 2026 | Brunn Carsten | President and CEO | A | Employee Stock Option (right to buy) | 415700 | $0.00 | 415,700.0000 | 26,003,606 | 9999.99% | 1.60% |
| Jan. 2, 2026 | Malik Kemal | Director | A | Common Stock | 2600 | $0.00 | 11,133.0000 | 26,003,606 | 30.47% | 0.01% |
| Jan. 2, 2026 | Malik Kemal | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2026 | Miljkovic Milos | Chief Medical Officer | A | Common Stock | 27000 | $0.00 | 62,393.0000 | 26,003,606 | 76.29% | 0.10% |
| Jan. 2, 2026 | Miljkovic Milos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 77000 | $0.00 | 77,000.0000 | 26,003,606 | 9999.99% | 0.30% |
| Jan. 2, 2026 | ZENNER PATRICK J | Director | A | Common Stock | 2600 | $0.00 | 12,974.0000 | 26,003,606 | 25.06% | 0.01% |
| Jan. 2, 2026 | ZENNER PATRICK J | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2026 | Seymour June Ann | Chief Accounting Officer | A | Common Stock | 6500 | $0.00 | 6,500.0000 | 26,003,606 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Seymour June Ann | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 26,003,606 | 9999.99% | 0.07% |
| Jan. 2, 2026 | Davis Blaine | Chief Financial Officer | A | Common Stock | 37000 | $0.00 | 131,811.0000 | 26,003,606 | 39.03% | 0.14% |
| Jan. 2, 2026 | Davis Blaine | Chief Financial Officer | A | Employee Stock Option (right to buy) | 109000 | $0.00 | 109,000.0000 | 26,003,606 | 9999.99% | 0.42% |
| Jan. 2, 2026 | BARABE TIMOTHY C | Director | A | Common Stock | 2600 | $0.00 | 56,966.0000 | 26,003,606 | 4.78% | 0.01% |
| Jan. 2, 2026 | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2026 | English Emily | Chief Operations Officer | A | Common Stock | 24000 | $0.00 | 94,226.0000 | 26,003,606 | 34.18% | 0.09% |
| Jan. 2, 2026 | English Emily | Chief Operations Officer | A | Employee Stock Option (right to buy) | 71000 | $0.00 | 71,000.0000 | 26,003,606 | 9999.99% | 0.27% |
| Jan. 2, 2026 | Singer Michael | Director | A | Common Stock | 2600 | $0.00 | 711,001.0000 | 26,003,606 | 0.37% | 0.01% |
| Jan. 2, 2026 | Singer Michael | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2026 | SPRINGER TIMOTHY A | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2026 | Kalayoglu Murat | Director | A | Common Stock | 2600 | $0.00 | 5,066,837.0000 | 26,003,606 | 0.05% | 0.01% |
| Jan. 2, 2026 | Kalayoglu Murat | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Dec. 30, 2025 | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 19,369.0000 | 26,003,606 | 27.91% | 0.03% |
| Dec. 30, 2025 | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 70,226.0000 | 26,003,606 | 11.96% | 0.03% |
| Dec. 16, 2025 | Bot Adrian Ion | Director | A | Stock Option (Right to Buy) | 17200 | $0.00 | 17,200.0000 | 26,003,606 | 9999.99% | 0.07% |
| Dec. 16, 2025 | Bot Adrian Ion | Director | A | Common Stock | 5800 | $0.00 | 5,800.0000 | 26,003,606 | 9999.99% | 0.02% |
| Dec. 4, 2025 | BARABE TIMOTHY C | Director | P | Common Stock | 30000 | $6.86 | 54,366.0000 | 26,003,606 | 123.12% | 0.12% |
| Nov. 28, 2025 | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 62,726.0000 | 26,003,606 | 13.58% | 0.03% |
| Nov. 28, 2025 | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 26,869.0000 | 26,003,606 | 21.82% | 0.03% |
| Nov. 18, 2025 | Singer Michael | Director | G | Common Stock | 20000 | $0.00 | 708,401.0000 | 26,003,606 | 2.75% | 0.08% |
| Oct. 27, 2025 | Seymour June Ann | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 26,003,606 | 9999.99% | 0.19% |
| May 12, 2025 | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 34,369.0000 | 25,936,101 | 17.91% | 0.03% |
| May 12, 2025 | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 55,226.0000 | 25,936,101 | 15.71% | 0.03% |
| April 15, 2025 | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 41,869.0000 | 25,936,101 | 15.19% | 0.03% |
| April 15, 2025 | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 47,726.0000 | 25,936,101 | 18.64% | 0.03% |
| April 11, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 6412 | $10.77 | 9,630,893.0000 | 25,936,101 | 0.07% | 0.02% |
| April 10, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 45144 | $10.43 | 9,591,104.0000 | 25,936,101 | 0.47% | 0.17% |
| April 10, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 3451 | $10.92 | 9,594,555.0000 | 25,936,101 | 0.04% | 0.01% |
| April 10, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 609 | $10.92 | 9,624,481.0000 | 25,936,101 | 0.01% | 0.00% |
| April 9, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 41604 | $9.43 | 9,545,782.0000 | 25,936,101 | 0.44% | 0.16% |
| April 9, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 31 | $9.95 | 9,615,906.0000 | 25,936,101 | 0.00% | 0.00% |
| April 9, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 7342 | $9.43 | 9,615,875.0000 | 25,936,101 | 0.08% | 0.03% |
| April 10, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 7966 | $10.43 | 9,623,872.0000 | 25,936,101 | 0.08% | 0.03% |
| April 11, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 36338 | $10.77 | 9,630,893.0000 | 25,936,101 | 0.38% | 0.14% |
| April 9, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 178 | $9.95 | 9,545,960.0000 | 25,936,101 | 0.00% | 0.00% |
| March 19, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 20234 | $14.97 | 9,426,929.0000 | 25,767,369 | 0.22% | 0.08% |
| March 18, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 14740 | $14.42 | 9,406,695.0000 | 25,767,369 | 0.16% | 0.06% |
| March 20, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 54889 | $15.59 | 9,481,818.0000 | 25,767,369 | 0.58% | 0.21% |
| Jan. 14, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 4022 | $18.00 | 9,391,955.0000 | 25,767,369 | 0.04% | 0.02% |
| Jan. 13, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 8983 | $17.78 | 9,387,933.0000 | 25,767,369 | 0.10% | 0.03% |
| Jan. 13, 2025 | SPRINGER TIMOTHY A | Director | P | Common Stock | 7962 | $16.86 | 9,378,950.0000 | 25,767,369 | 0.08% | 0.03% |
| Jan. 10, 2025 | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 9000 | $0.00 | 67,432.0000 | 25,767,369 | 11.78% | 0.03% |
| Jan. 10, 2025 | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 9000 | $3.23 | 62,490.0000 | 25,767,369 | 16.83% | 0.03% |
| Jan. 3, 2025 | English Emily | Chief Operations Officer | S | Common Stock | 891 | $16.72 | 41,132.0000 | 25,767,369 | 2.12% | 0.00% |
| Jan. 3, 2025 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 2417 | $16.72 | 64,716.0000 | 25,767,369 | 3.60% | 0.01% |
| Jan. 6, 2025 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 2458 | $16.83 | 62,258.0000 | 25,767,369 | 3.80% | 0.01% |
| Jan. 3, 2025 | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 932 | $16.72 | 36,341.0000 | 25,767,369 | 2.50% | 0.00% |
| Jan. 6, 2025 | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 948 | $16.83 | 35,393.0000 | 25,767,369 | 2.61% | 0.00% |
| Jan. 3, 2025 | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 1264 | $16.72 | 54,776.0000 | 25,767,369 | 2.26% | 0.00% |
| Jan. 6, 2025 | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 1286 | $16.83 | 53,490.0000 | 25,767,369 | 2.35% | 0.00% |
| Jan. 6, 2025 | English Emily | Chief Operations Officer | S | Common Stock | 906 | $16.83 | 40,226.0000 | 25,767,369 | 2.20% | 0.00% |
| Jan. 3, 2025 | Brunn Carsten | President and CEO | S | Common Stock | 8563 | $16.72 | 212,804.0000 | 25,767,369 | 3.87% | 0.03% |
| Jan. 6, 2025 | Brunn Carsten | President and CEO | S | Common Stock | 8708 | $16.83 | 204,096.0000 | 25,767,369 | 4.09% | 0.03% |
| Jan. 3, 2025 | Davis Blaine | Chief Financial Officer | S | Common Stock | 3961 | $16.72 | 98,839.0000 | 25,767,369 | 3.85% | 0.02% |
| Jan. 6, 2025 | Davis Blaine | Chief Financial Officer | S | Common Stock | 4028 | $16.83 | 94,811.0000 | 25,767,369 | 4.08% | 0.02% |
| Jan. 2, 2025 | Singer Michael | Director | A | Common Stock | 2600 | $0.00 | 728,401.0000 | 25,767,369 | 0.36% | 0.01% |
| Jan. 2, 2025 | ZENNER PATRICK J | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 15,400.0000 | 25,767,369 | 102.63% | 0.03% |
| Jan. 2, 2025 | Miljkovic Milos | Chief Medical Officer | A | Common Stock | 19000 | $0.00 | 37,273.0000 | 25,767,369 | 103.98% | 0.07% |
| Jan. 2, 2025 | Miljkovic Milos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 56000 | $0.00 | 56,000.0000 | 25,767,369 | 9999.99% | 0.22% |
| Jan. 2, 2025 | Kalayoglu Murat | Director | A | Common Stock | 2600 | $0.00 | 5,064,237.0000 | 25,767,369 | 0.05% | 0.01% |
| Jan. 2, 2025 | Kalayoglu Murat | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| Jan. 2, 2025 | BARABE TIMOTHY C | Director | A | Common Stock | 2600 | $0.00 | 24,366.0000 | 25,767,369 | 11.95% | 0.01% |
| Jan. 2, 2025 | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| Jan. 2, 2025 | SPRINGER TIMOTHY A | Director | A | Common Stock | 2600 | $0.00 | 9,370,988.0000 | 25,767,369 | 0.03% | 0.01% |
| Jan. 2, 2025 | SPRINGER TIMOTHY A | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| Jan. 2, 2025 | Malik Kemal | Director | A | Common Stock | 2600 | $0.00 | 8,533.0000 | 25,767,369 | 43.82% | 0.01% |
| Jan. 2, 2025 | Malik Kemal | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| Jan. 2, 2025 | Kurtoglu Metin | Chief Technology Officer | A | Common Stock | 16100 | $0.00 | 67,133.0000 | 25,767,369 | 31.55% | 0.06% |
| Jan. 2, 2025 | Kurtoglu Metin | Chief Technology Officer | A | Employee Stock Option (right to buy) | 47400 | $0.00 | 47,400.0000 | 25,767,369 | 9999.99% | 0.18% |
| Jan. 2, 2025 | ZENNER PATRICK J | Director | A | Common Stock | 2600 | $0.00 | 10,374.0000 | 25,767,369 | 33.44% | 0.01% |
| Jan. 2, 2025 | Singer Michael | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| Jan. 2, 2025 | COX CARRIE SMITH | Director | A | Common Stock | 2600 | $0.00 | 15,629.0000 | 25,767,369 | 19.96% | 0.01% |
| Jan. 2, 2025 | COX CARRIE SMITH | Director | A | Stock Option (Right to Buy) | 8000 | $0.00 | 16,266.0000 | 25,767,369 | 96.78% | 0.03% |
| Jan. 2, 2025 | DeSilva Nishan M | Director | A | Common Stock | 2600 | $0.00 | 8,766.0000 | 25,767,369 | 42.17% | 0.01% |
| Jan. 2, 2025 | DeSilva Nishan M | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 15,400.0000 | 25,767,369 | 102.63% | 0.03% |
| Jan. 2, 2025 | Brunn Carsten | President and CEO | A | Common Stock | 57500 | $0.00 | 221,367.0000 | 25,767,369 | 35.09% | 0.22% |
| Jan. 2, 2025 | Brunn Carsten | President and CEO | A | Employee Stock Option (right to buy) | 169100 | $0.00 | 368,133.0000 | 25,767,369 | 84.96% | 0.66% |
| Jan. 2, 2025 | Jewell Christopher M | Chief Scientific Officer | A | Common Stock | 16100 | $0.00 | 56,040.0000 | 25,767,369 | 40.31% | 0.06% |
| Jan. 2, 2025 | Jewell Christopher M | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 47400 | $0.00 | 47,400.0000 | 25,767,369 | 9999.99% | 0.18% |
| Jan. 2, 2025 | English Emily | Chief Operations Officer | A | Common Stock | 16100 | $0.00 | 42,023.0000 | 25,767,369 | 62.11% | 0.06% |
| Jan. 2, 2025 | English Emily | Chief Operations Officer | A | Employee Stock Option (right to buy) | 47400 | $0.00 | 47,400.0000 | 25,767,369 | 9999.99% | 0.18% |
| Jan. 2, 2025 | Davis Blaine | Chief Financial Officer | A | Common Stock | 22000 | $0.00 | 102,800.0000 | 25,767,369 | 27.23% | 0.09% |
| Jan. 2, 2025 | Davis Blaine | Chief Financial Officer | A | Employee Stock Option (right to buy) | 64600 | $0.00 | 168,266.0000 | 25,767,369 | 62.32% | 0.25% |
| Dec. 26, 2024 | Singer Michael | Director | G | Common Stock | 20000 | $0.00 | 725,801.0000 | 23,896,525 | 2.68% | 0.08% |
| Dec. 26, 2024 | English Emily | SVP, Head of Manufacturing | M | Stock Option (Right to Buy) | 7650 | $0.00 | 49,369.0000 | 23,896,525 | 13.42% | 0.03% |
| Dec. 26, 2024 | English Emily | SVP, Head of Manufacturing | M | Common Stock | 7650 | $3.30 | 25,923.0000 | 23,896,525 | 41.87% | 0.03% |
| Dec. 19, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 3376 | $18.93 | 9,341,407.0000 | 23,896,525 | 0.04% | 0.01% |
| Dec. 19, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 10529 | $18.35 | 9,338,031.0000 | 23,896,525 | 0.11% | 0.04% |
| Dec. 19, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 11303 | $17.39 | 9,327,502.0000 | 23,896,525 | 0.12% | 0.05% |
| Dec. 23, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 5181 | $19.00 | 9,368,388.0000 | 23,896,525 | 0.06% | 0.02% |
| Dec. 20, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 21800 | $18.94 | 9,363,207.0000 | 23,896,525 | 0.23% | 0.09% |
| Dec. 10, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 2901 | $0.00 | 79,099.0000 | 23,896,525 | 3.54% | 0.01% |
| Dec. 9, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 4539 | $25.83 | 51,033.0000 | 23,896,525 | 8.17% | 0.02% |
| Dec. 9, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 6224 | $25.26 | 55,572.0000 | 23,896,525 | 10.07% | 0.03% |
| Dec. 10, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 2901 | $1.41 | 53,934.0000 | 23,896,525 | 5.68% | 0.01% |
| Dec. 10, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 2901 | $24.35 | 51,033.0000 | 23,896,525 | 5.38% | 0.01% |
| Dec. 9, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 10763 | $0.00 | 82,000.0000 | 23,896,525 | 11.60% | 0.05% |
| Dec. 9, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 10763 | $1.41 | 61,796.0000 | 23,896,525 | 21.09% | 0.05% |
| Nov. 19, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 200 | $1.41 | 51,233.0000 | 23,896,525 | 0.39% | 0.00% |
| Nov. 19, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 200 | $19.50 | 51,033.0000 | 23,896,525 | 0.39% | 0.00% |
| Nov. 20, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 5700 | $1.41 | 56,733.0000 | 23,896,525 | 11.17% | 0.02% |
| Nov. 20, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 5600 | $17.28 | 51,133.0000 | 23,896,525 | 9.87% | 0.02% |
| Nov. 20, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 100 | $18.09 | 51,033.0000 | 23,896,525 | 0.20% | 0.00% |
| Nov. 20, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 14000 | $0.00 | 76,432.0000 | 23,896,525 | 15.48% | 0.06% |
| Nov. 20, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 14000 | $3.23 | 39,940.0000 | 23,896,525 | 53.97% | 0.06% |
| Nov. 19, 2024 | Singer Michael | Director | G | Common Stock | 28821 | $0.00 | 745,801.0000 | 23,896,525 | 3.72% | 0.12% |
| Nov. 21, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 32789 | $0.00 | 92,763.0000 | 23,896,525 | 26.12% | 0.14% |
| Nov. 20, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 5700 | $0.00 | 125,552.0000 | 23,896,525 | 4.34% | 0.02% |
| Nov. 19, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 200 | $0.00 | 131,252.0000 | 23,896,525 | 0.15% | 0.00% |
| Nov. 21, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 32789 | $16.67 | 51,033.0000 | 23,896,525 | 39.12% | 0.14% |
| Nov. 21, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 32789 | $1.41 | 83,822.0000 | 23,896,525 | 64.25% | 0.14% |
| Nov. 15, 2024 | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 20000 | $17.14 | 18,273.0000 | 23,896,525 | 52.26% | 0.08% |
| Nov. 14, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 74157 | $16.19 | 8,958,416.0000 | 23,896,525 | 0.83% | 0.31% |
| Nov. 14, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 22242 | $16.97 | 8,980,658.0000 | 23,896,525 | 0.25% | 0.09% |
| Nov. 15, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 277246 | $17.09 | 9,257,904.0000 | 23,896,525 | 3.09% | 1.16% |
| Nov. 18, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 38114 | $17.96 | 9,296,018.0000 | 23,896,525 | 0.41% | 0.16% |
| Nov. 18, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 20181 | $18.42 | 9,316,199.0000 | 23,896,525 | 0.22% | 0.08% |
| Nov. 14, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 25900 | $1.41 | 76,933.0000 | 23,896,525 | 50.75% | 0.11% |
| Nov. 14, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 21900 | $16.33 | 55,033.0000 | 23,896,525 | 28.47% | 0.09% |
| Nov. 14, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 4000 | $17.06 | 51,033.0000 | 23,896,525 | 7.27% | 0.02% |
| Nov. 15, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 22068 | $1.41 | 73,101.0000 | 23,896,525 | 43.24% | 0.09% |
| Nov. 15, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 22068 | $17.20 | 51,033.0000 | 23,896,525 | 30.19% | 0.09% |
| Nov. 18, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Common Stock | 34400 | $1.41 | 85,433.0000 | 23,896,525 | 67.41% | 0.14% |
| Nov. 18, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 16672 | $18.19 | 68,761.0000 | 23,896,525 | 19.51% | 0.07% |
| Nov. 18, 2024 | Kurtoglu Metin | Chief Technology Officer | S | Common Stock | 17728 | $18.58 | 51,033.0000 | 23,896,525 | 25.78% | 0.07% |
| Nov. 14, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 25900 | $0.00 | 187,920.0000 | 23,896,525 | 12.11% | 0.11% |
| Nov. 15, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 22068 | $0.00 | 165,852.0000 | 23,896,525 | 11.74% | 0.09% |
| Nov. 18, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 34400 | $0.00 | 131,452.0000 | 23,896,525 | 20.74% | 0.14% |
| Nov. 14, 2024 | Miljkovic Milos | Chief Medical Officer | M | Common Stock | 35000 | $3.23 | 53,273.0000 | 23,896,525 | 191.54% | 0.15% |
| Nov. 14, 2024 | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 35000 | $16.13 | 18,273.0000 | 23,896,525 | 65.70% | 0.15% |
| Nov. 15, 2024 | Miljkovic Milos | Chief Medical Officer | M | Common Stock | 20000 | $3.23 | 38,273.0000 | 23,896,525 | 109.45% | 0.08% |
| Nov. 14, 2024 | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 35000 | $0.00 | 50,528.0000 | 23,896,525 | 40.92% | 0.15% |
| Nov. 15, 2024 | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 30,528.0000 | 23,896,525 | 39.58% | 0.08% |
| Nov. 14, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 36050 | $3.23 | 61,990.0000 | 23,896,525 | 138.97% | 0.15% |
| Nov. 14, 2024 | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 18550 | $16.34 | 43,440.0000 | 23,896,525 | 29.92% | 0.08% |
| Nov. 14, 2024 | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 17500 | $17.02 | 25,940.0000 | 23,896,525 | 40.29% | 0.07% |
| Nov. 15, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 16065 | $3.23 | 42,005.0000 | 23,896,525 | 61.93% | 0.07% |
| Nov. 15, 2024 | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 16065 | $17.06 | 25,940.0000 | 23,896,525 | 38.25% | 0.07% |
| Nov. 14, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 36050 | $0.00 | 106,497.0000 | 23,896,525 | 25.29% | 0.15% |
| Nov. 15, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 16065 | $0.00 | 90,432.0000 | 23,896,525 | 15.08% | 0.07% |
| Oct. 11, 2024 | Hoge Elizabeth | TenPercentOwner | M | Series A Non-Voting Convertible Preferred Stock | 45551 | $0.00 | 56,402.2540 | 23,896,525 | 44.68% | 0.19% |
| Oct. 11, 2024 | Kalayoglu Murat | Director | M | Common Stock | 1518373 | $0.00 | 5,061,637.0000 | 23,896,525 | 42.85% | 6.35% |
| Oct. 11, 2024 | Kalayoglu Murat | Director | M | Series A Non-Voting Convertible Preferred Stock | 45551 | $0.00 | 56,402.2540 | 23,896,525 | 44.68% | 0.19% |
| Oct. 11, 2024 | Hoge Elizabeth | TenPercentOwner | M | Common Stock | 1518373 | $0.00 | 5,061,637.0000 | 23,896,525 | 42.85% | 6.35% |
| Oct. 4, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 4879 | $23.93 | 8,884,259.0000 | 23,896,525 | 0.05% | 0.02% |
| Oct. 2, 2024 | SPRINGER TIMOTHY A | Director | J | Warrant (Right to Buy) | 133632 | $0.00 | 167,040.0000 | 23,896,525 | 44.44% | 0.56% |
| Oct. 4, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 16650 | $23.57 | 8,879,380.0000 | 23,896,525 | 0.19% | 0.07% |
| Oct. 4, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 48880 | $22.35 | 8,862,730.0000 | 23,896,525 | 0.55% | 0.20% |
| Oct. 4, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 9892 | $21.35 | 8,813,850.0000 | 23,896,525 | 0.11% | 0.04% |
| Oct. 3, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 8043 | $21.86 | 8,803,958.0000 | 23,896,525 | 0.09% | 0.03% |
| Oct. 3, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 21278 | $21.17 | 8,795,915.0000 | 23,896,525 | 0.24% | 0.09% |
| Oct. 3, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 50489 | $20.18 | 8,774,637.0000 | 23,896,525 | 0.58% | 0.21% |
| Oct. 3, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 10249 | $19.01 | 8,724,148.0000 | 23,896,525 | 0.12% | 0.04% |
| Oct. 3, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 29847 | $18.25 | 8,713,899.0000 | 23,896,525 | 0.34% | 0.12% |
| Oct. 2, 2024 | SPRINGER TIMOTHY A | Director | J | Common Stock | 317879 | $0.00 | 8,884,259.0000 | 23,896,525 | 3.71% | 1.33% |
| Oct. 2, 2024 | SPRINGER TIMOTHY A | Director | J | Common Stock | 2119193 | $0.00 | 8,884,259.0000 | 23,896,525 | 19.26% | 8.87% |
| Oct. 2, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 5514 | $17.38 | 8,684,052.0000 | 23,896,525 | 0.06% | 0.02% |
| Oct. 2, 2024 | SPRINGER TIMOTHY A | Director | J | Common Stock | 1801314 | $0.00 | 8,678,538.0000 | 23,896,525 | 26.19% | 7.54% |
| Oct. 2, 2024 | SPRINGER TIMOTHY A | Director | J | Warrant (Right to Buy) | 20045 | $0.00 | 167,040.0000 | 23,896,525 | 13.64% | 0.08% |
| Oct. 2, 2024 | SPRINGER TIMOTHY A | Director | J | Warrant (Right to Buy) | 113587 | $0.00 | 167,040.0000 | 23,896,525 | 212.50% | 0.48% |
| Sept. 25, 2024 | SPRINGER TIMOTHY A | Director | M | Common Stock | 1636832 | $0.00 | 8,678,538.0000 | 17,816,238 | 23.24% | 9.19% |
| Sept. 25, 2024 | SPRINGER TIMOTHY A | Director | M | Series B Non-Voting Convertible Preferred Stock | 1636832 | $0.00 | 0.0000 | 17,816,238 | 100.00% | 9.19% |
| Sept. 25, 2024 | SPRINGER TIMOTHY A | Director | M | Common Stock | 1307 | $0.00 | 8,678,538.0000 | 17,816,238 | 0.02% | 0.01% |
| Sept. 25, 2024 | SPRINGER TIMOTHY A | Director | M | Series B Non-Voting Convertible Preferred Stock | 1307 | $0.00 | 0.0000 | 17,816,238 | 100.00% | 0.01% |
| Sept. 25, 2024 | SPRINGER TIMOTHY A | Director | M | Common Stock | 721361 | $0.00 | 8,678,538.0000 | 17,816,238 | 9.07% | 4.05% |
| Sept. 25, 2024 | SPRINGER TIMOTHY A | Director | M | Series B Non-Voting Convertible Preferred Stock | 721361 | $0.00 | 0.0000 | 17,816,238 | 100.00% | 4.05% |
| Aug. 12, 2024 | BARABE TIMOTHY C | Director | P | Common Stock | 7500 | $12.70 | 21,766.0000 | 17,816,238 | 52.57% | 0.04% |
| Aug. 12, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 8016 | $12.72 | 6,319,038.0000 | 17,816,238 | 0.13% | 0.04% |
| July 2, 2024 | SPRINGER TIMOTHY A | Director | A | Series B Non-Voting Convertible Preferred Stock | 721361 | $20.00 | 2,359,500.0000 | 17,816,238 | 44.04% | 4.05% |
| July 2, 2024 | SPRINGER TIMOTHY A | Director | A | Series B Non-Voting Convertible Preferred Stock | 1307 | $20.00 | 2,359,500.0000 | 17,816,238 | 0.06% | 0.01% |
| July 2, 2024 | SPRINGER TIMOTHY A | Director | A | Series B Non-Voting Convertible Preferred Stock | 1636832 | $20.00 | 2,359,500.0000 | 17,816,238 | 226.50% | 9.19% |
| July 1, 2024 | Malik Kemal | Director | A | Common Stock | 5933 | $0.00 | 5,933.0000 | 17,816,238 | 9999.99% | 0.03% |
| July 1, 2024 | Malik Kemal | Director | A | Stock Option (Right to Buy) | 7600 | $0.00 | 7,600.0000 | 17,816,238 | 9999.99% | 0.04% |
| April 8, 2024 | Singer Michael | Director | M | Common Stock | 55746 | $0.00 | 287,480.0000 | 5,515,836 | 24.06% | 1.01% |
| April 8, 2024 | Singer Michael | Director | M | Common Stock | 14535 | $0.00 | 237,888.0000 | 5,515,836 | 6.51% | 0.26% |
| April 8, 2024 | Singer Michael | Director | M | Common Stock | 110151 | $0.00 | 237,888.0000 | 5,515,836 | 86.23% | 2.00% |
| April 8, 2024 | Singer Michael | Director | M | Common Stock | 377208 | $0.00 | 614,557.0000 | 5,515,836 | 158.93% | 6.84% |
| April 8, 2024 | Singer Michael | Director | M | Common Stock | 94568 | $0.00 | 237,888.0000 | 5,515,836 | 65.98% | 1.71% |
| April 8, 2024 | Singer Michael | Director | M | Common Stock | 94568 | $0.00 | 237,888.0000 | 5,515,836 | 65.98% | 1.71% |
| April 8, 2024 | Singer Michael | Director | M | Series A Non-Voting Convertible Preferred Stock | 3305 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.06% |
| April 8, 2024 | Singer Michael | Director | M | Series A Non-Voting Convertible Preferred Stock | 11316 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.21% |
| April 8, 2024 | Singer Michael | Director | M | Series A Non-Voting Convertible Preferred Stock | 1672 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.03% |
| April 8, 2024 | Singer Michael | Director | M | Series A Non-Voting Convertible Preferred Stock | 210 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.00% |
| April 8, 2024 | Singer Michael | Director | M | Series A Non-Voting Convertible Preferred Stock | 436 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.01% |
| April 8, 2024 | Singer Michael | Director | M | Series A Non-Voting Convertible Preferred Stock | 2837 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.05% |
| April 8, 2024 | Singer Michael | Director | M | Series A Non-Voting Convertible Preferred Stock | 2837 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.05% |
| April 8, 2024 | Kalayoglu Murat | Director | M | Common Stock | 491853 | $0.00 | 3,543,264.0000 | 5,515,836 | 16.12% | 8.92% |
| April 8, 2024 | Kalayoglu Murat | Director | M | Common Stock | 2926764 | $0.00 | 3,543,264.0000 | 5,515,836 | 474.74% | 53.06% |
| April 8, 2024 | Kalayoglu Murat | Director | M | Series A Non-Voting Convertible Preferred Stock | 14756 | $0.00 | 101,953.4440 | 5,515,836 | 12.64% | 0.27% |
| April 8, 2024 | Kalayoglu Murat | Director | M | Series A Non-Voting Convertible Preferred Stock | 87803 | $0.00 | 101,953.4440 | 5,515,836 | 46.27% | 1.59% |
| April 8, 2024 | SPRINGER TIMOTHY A | Director | M | Series A Non-Voting Convertible Preferred Stock | 123925 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 2.25% |
| April 8, 2024 | SPRINGER TIMOTHY A | Director | M | Common Stock | 4130846 | $0.00 | 6,311,022.0000 | 5,515,836 | 189.47% | 74.89% |
| April 8, 2024 | SPRINGER TIMOTHY A | Director | M | Series A Non-Voting Convertible Preferred Stock | 24785 | $0.00 | 0.0000 | 5,515,836 | 100.00% | 0.45% |
| April 8, 2024 | SPRINGER TIMOTHY A | Director | M | Common Stock | 826169 | $0.00 | 6,311,022.0000 | 5,515,836 | 15.06% | 14.98% |
| April 8, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4276 | $0.00 | 33,265.0000 | 5,515,836 | 11.39% | 0.08% |
| April 8, 2024 | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 142547 | $0.00 | 175,812.0000 | 5,515,836 | 428.52% | 2.58% |
| April 8, 2024 | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 2566 | $0.00 | 23,433.0000 | 5,515,836 | 9.87% | 0.05% |
| April 8, 2024 | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 85528 | $0.00 | 108,961.0000 | 5,515,836 | 364.99% | 1.55% |
| April 8, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 6415 | $0.00 | 65,499.0000 | 5,515,836 | 8.92% | 0.12% |
| April 8, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 213820 | $0.00 | 279,319.0000 | 5,515,836 | 326.45% | 3.88% |
| April 8, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 428 | $0.00 | 65,499.0000 | 5,515,836 | 0.65% | 0.01% |
| April 8, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 14254 | $0.00 | 79,753.0000 | 5,515,836 | 21.76% | 0.26% |
| April 8, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 428 | $0.00 | 65,499.0000 | 5,515,836 | 0.65% | 0.01% |
| April 8, 2024 | Kurtoglu Metin | Chief Technology Officer | M | Stock Option (Right to Buy) | 14254 | $0.00 | 79,753.0000 | 5,515,836 | 21.76% | 0.26% |
| April 8, 2024 | Hoge Elizabeth | TenPercentOwner | C | Common Stock | 2926764 | $0.00 | 3,543,264.0000 | 5,515,836 | 474.74% | 53.06% |
| April 8, 2024 | Hoge Elizabeth | TenPercentOwner | C | Common Stock | 491853 | $0.00 | 3,543,264.0000 | 5,515,836 | 16.12% | 8.92% |
| April 8, 2024 | Hoge Elizabeth | TenPercentOwner | C | Series A Non-Voting Convertible Preferred Stock | 87803 | $0.00 | 101,953.4440 | 5,515,836 | 46.27% | 1.59% |
| April 8, 2024 | Hoge Elizabeth | TenPercentOwner | C | Series A Non-Voting Convertible Preferred Stock | 14756 | $0.00 | 101,953.4440 | 5,515,836 | 12.64% | 0.27% |
| April 8, 2024 | Singer Michael | Director | M | Common Stock | 7005 | $0.00 | 237,888.0000 | 5,515,836 | 3.03% | 0.13% |
| March 12, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 1200 | $0.61 | 40,613,092.0000 | 5,397,597 | 0.00% | 0.02% |
| Jan. 17, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 800 | $0.69 | 40,602,692.0000 | 5,397,597 | 0.00% | 0.01% |
| Feb. 6, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 800 | $0.65 | 40,603,492.0000 | 5,397,597 | 0.00% | 0.01% |
| Feb. 7, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 2400 | $0.66 | 40,605,892.0000 | 5,397,597 | 0.01% | 0.04% |
| March 8, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 4800 | $0.66 | 40,610,692.0000 | 5,397,597 | 0.01% | 0.09% |
| March 11, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 1200 | $0.65 | 40,611,892.0000 | 5,397,597 | 0.00% | 0.02% |
| March 13, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 3200 | $0.58 | 40,616,292.0000 | 5,397,597 | 0.01% | 0.06% |
| March 14, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 2000 | $0.53 | 40,618,292.0000 | 5,397,597 | 0.00% | 0.04% |
| March 15, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 1200 | $0.56 | 40,619,492.0000 | 5,397,597 | 0.00% | 0.02% |
| March 18, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 800 | $0.61 | 40,620,292.0000 | 5,397,597 | 0.00% | 0.01% |
| March 26, 2024 | SPRINGER TIMOTHY A | Director | M | Common Stock | 1970443 | $1.46 | 40,601,892.0000 | 5,397,597 | 5.10% | 36.51% |
| March 26, 2024 | SPRINGER TIMOTHY A | Director | M | Warrant (Right to Buy) | 1970443 | $0.00 | 0.0000 | 5,397,597 | 100.00% | 36.51% |
| March 18, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 19044 | $0.60 | 38,631,449.0000 | 5,397,597 | 0.05% | 0.35% |
| March 14, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 648372 | $0.54 | 38,074,905.0000 | 5,397,597 | 1.73% | 12.01% |
| March 15, 2024 | SPRINGER TIMOTHY A | Director | P | Common Stock | 537500 | $0.59 | 38,612,405.0000 | 5,397,597 | 1.41% | 9.96% |
| Jan. 2, 2024 | Singer Michael | Director | A | Common Stock | 178000 | $0.00 | 625,394.0000 | 5,397,597 | 39.79% | 3.30% |
| Jan. 2, 2024 | Singer Michael | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Dec. 22, 2023 | Singer Michael | Director | G | Series A Convertible Preferred Stock | 3000 | $0.00 | 28,918.0920 | 5,101,459 | 9.40% | 0.06% |
| Jan. 2, 2024 | Davis Blaine | Chief Financial Officer | A | Common Stock | 2424000 | $0.00 | 2,424,000.0000 | 5,397,597 | 9999.99% | 44.91% |
| Jan. 2, 2024 | Davis Blaine | Chief Financial Officer | A | Employee Stock Option (right to buy) | 3110000 | $0.00 | 3,110,000.0000 | 5,397,597 | 9999.99% | 57.62% |
| Jan. 2, 2024 | Jewell Christopher M | Chief Scientific Officer | A | Common Stock | 778200 | $0.00 | 778,200.0000 | 5,397,597 | 9999.99% | 14.42% |
| Jan. 2, 2024 | Jewell Christopher M | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 998000 | $0.00 | 998,000.0000 | 5,397,597 | 9999.99% | 18.49% |
| Jan. 2, 2024 | Brunn Carsten | President and CEO | A | Common Stock | 4654100 | $0.00 | 4,916,056.0000 | 5,397,597 | 1776.67% | 86.23% |
| Jan. 2, 2024 | Brunn Carsten | President and CEO | A | Employee Stock Option (right to buy) | 5971000 | $0.00 | 5,971,000.0000 | 5,397,597 | 9999.99% | 100.00% |
| Jan. 2, 2024 | Sallin Aymeric | Director | A | Common Stock | 178000 | $0.00 | 178,000.0000 | 5,397,597 | 9999.99% | 3.30% |
| Jan. 2, 2024 | Sallin Aymeric | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | BARABE TIMOTHY C | Director | A | Common Stock | 178000 | $0.00 | 428,013.0000 | 5,397,597 | 71.20% | 3.30% |
| Jan. 2, 2024 | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | SPRINGER TIMOTHY A | Director | A | Common Stock | 178000 | $0.00 | 37,426,533.0000 | 5,397,597 | 0.48% | 3.30% |
| Jan. 2, 2024 | SPRINGER TIMOTHY A | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | Miljkovic Milos | Chief Medical Officer | A | Common Stock | 548200 | $0.00 | 548,200.0000 | 5,397,597 | 9999.99% | 10.16% |
| Jan. 2, 2024 | Miljkovic Milos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 703000 | $0.00 | 703,000.0000 | 5,397,597 | 9999.99% | 13.02% |
| Jan. 2, 2024 | DeSilva Nishan M | Director | A | Common Stock | 178000 | $0.00 | 185,000.0000 | 5,397,597 | 2542.86% | 3.30% |
| Jan. 2, 2024 | DeSilva Nishan M | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | COX CARRIE SMITH | Director | A | Common Stock | 178000 | $0.00 | 390,881.0000 | 5,397,597 | 83.61% | 3.30% |
| Jan. 2, 2024 | COX CARRIE SMITH | Director | A | Stock Option (Right to Buy) | 248000 | $0.00 | 248,000.0000 | 5,397,597 | 9999.99% | 4.59% |
| Jan. 2, 2024 | ZENNER PATRICK J | Director | A | Common Stock | 178000 | $0.00 | 233,248.0000 | 5,397,597 | 322.18% | 3.30% |
| Jan. 2, 2024 | ZENNER PATRICK J | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | Kalayoglu Murat | Director | A | Common Stock | 178000 | $0.00 | 3,739,438.0000 | 5,397,597 | 5.00% | 3.30% |
| Jan. 2, 2024 | Kalayoglu Murat | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | Kurtoglu Metin | Chief Operating Officer | A | Common Stock | 1531000 | $0.00 | 1,531,000.0000 | 5,397,597 | 9999.99% | 28.36% |
| Jan. 2, 2024 | Kurtoglu Metin | Chief Operating Officer | A | Employee Stock Option (right to buy) | 1965000 | $0.00 | 1,965,000.0000 | 5,397,597 | 9999.99% | 36.41% |
| Nov. 13, 2023 | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 6410 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.13% |
| Nov. 13, 2023 | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 75000 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.47% |
| Nov. 13, 2023 | Myers Scott Dunseth | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | Myers Scott Dunseth | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | Myers Scott Dunseth | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | Myers Scott Dunseth | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 10328 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 6410 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.13% |
| Nov. 13, 2023 | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 87500 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.72% |
| Nov. 13, 2023 | COX CARRIE SMITH | Director | D | Stock Option (Right to Buy) | 20000 | $0.74 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | COX CARRIE SMITH | Director | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.59% |
| Nov. 13, 2023 | COX CARRIE SMITH | Director | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 1.18% |
| Nov. 13, 2023 | COX CARRIE SMITH | Director | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 1.18% |
| Nov. 13, 2023 | COX CARRIE SMITH | Director | D | Stock Option (Right to Buy) | 107500 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 2.11% |
| Nov. 13, 2023 | Kurtoglu Metin | Chief Operations Officer | A | Stock Option (Right to Buy) | 6415 | $0.00 | 6,414.6820 | 5,101,459 | 9999.99% | 0.13% |
| Nov. 13, 2023 | Kurtoglu Metin | Chief Operations Officer | A | Stock Option (Right to Buy) | 428 | $0.00 | 427.6450 | 5,101,459 | 9999.99% | 0.01% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Common Stock | 55000 | $2.06 | 728,081.0000 | 5,101,459 | 7.02% | 1.08% |
| Nov. 13, 2023 | Jewell Christopher M | Chief Scientific Officer | A | Stock Option (Right to Buy) | 4276 | $0.00 | 4,276.4540 | 5,101,459 | 9999.99% | 0.08% |
| Nov. 13, 2023 | Singer Michael | Director | A | Common Stock | 110123 | $0.00 | 170,964.0000 | 5,101,459 | 181.00% | 2.16% |
| Nov. 13, 2023 | Singer Michael | Director | J | Common Stock | 197663 | $0.00 | 364,957.0000 | 5,101,459 | 118.15% | 3.87% |
| Nov. 13, 2023 | Singer Michael | Director | J | Common Stock | 29212 | $0.00 | 196,506.0000 | 5,101,459 | 17.46% | 0.57% |
| Nov. 13, 2023 | Singer Michael | Director | J | Common Stock | 3670 | $0.00 | 170,964.0000 | 5,101,459 | 2.19% | 0.07% |
| Nov. 13, 2023 | Singer Michael | Director | J | Common Stock | 49555 | $0.00 | 170,964.0000 | 5,101,459 | 40.82% | 0.97% |
| Nov. 13, 2023 | Singer Michael | Director | J | Common Stock | 49555 | $0.00 | 170,964.0000 | 5,101,459 | 40.82% | 0.97% |
| Nov. 13, 2023 | Singer Michael | Director | J | Common Stock | 7616 | $0.00 | 170,964.0000 | 5,101,459 | 4.66% | 0.15% |
| Nov. 13, 2023 | Singer Michael | Director | A | Series A Non-Voting Convertible Preferred Stock | 6305 | $0.00 | 9,787.8290 | 5,101,459 | 181.00% | 0.12% |
| Nov. 13, 2023 | Singer Michael | Director | J | Series A Non-Voting Convertible Preferred Stock | 11316 | $0.00 | 20,893.9400 | 5,101,459 | 118.15% | 0.22% |
| Nov. 13, 2023 | Singer Michael | Director | J | Series A Non-Voting Convertible Preferred Stock | 1672 | $0.00 | 11,250.0660 | 5,101,459 | 17.46% | 0.03% |
| Nov. 13, 2023 | Singer Michael | Director | J | Series A Non-Voting Convertible Preferred Stock | 210 | $0.00 | 9,787.8290 | 5,101,459 | 2.19% | 0.00% |
| Nov. 13, 2023 | Singer Michael | Director | J | Series A Non-Voting Convertible Preferred Stock | 2837 | $0.00 | 9,787.8290 | 5,101,459 | 40.82% | 0.06% |
| Nov. 13, 2023 | Singer Michael | Director | J | Series A Non-Voting Convertible Preferred Stock | 2837 | $0.00 | 9,787.8290 | 5,101,459 | 40.82% | 0.06% |
| Nov. 13, 2023 | Singer Michael | Director | J | Series A Non-Voting Convertible Preferred Stock | 436 | $0.00 | 9,787.8290 | 5,101,459 | 4.66% | 0.01% |
| Nov. 13, 2023 | Kalayoglu Murat | Director | A | Common Stock | 257739 | $0.00 | 3,561,438.0000 | 5,101,459 | 7.80% | 5.05% |
| Nov. 13, 2023 | Kalayoglu Murat | Director | J | Common Stock | 3303699 | $0.00 | 3,561,438.0000 | 5,101,459 | 1281.80% | 64.76% |
| Nov. 13, 2023 | Kalayoglu Murat | Director | A | Series A Non-Voting Convertible Preferred Stock | 14756 | $0.00 | 15,375.2360 | 5,101,459 | 2381.37% | 0.29% |
| Nov. 13, 2023 | Kalayoglu Murat | Director | J | Series A Non-Voting Convertible Preferred Stock | 189137 | $0.00 | 203,892.3760 | 5,101,459 | 1281.80% | 3.71% |
| Nov. 13, 2023 | Kalayoglu Murat | Director | P | Series A Non-Voting Convertible Preferred Stock | 620 | $249999.98 | 15,375.2360 | 5,101,459 | 4.20% | 0.01% |
| Nov. 13, 2023 | Miljkovic Milos | Chief Medical Officer | A | Stock Option (Right to Buy) | 2566 | $0.00 | 2,565.8720 | 5,101,459 | 9999.99% | 0.05% |
| Nov. 13, 2023 | Kurtoglu Metin | Chief Operations Officer | A | Stock Option (Right to Buy) | 428 | $0.00 | 427.6450 | 5,101,459 | 9999.99% | 0.01% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Common Stock | 13600 | $2.06 | 714,481.0000 | 5,101,459 | 1.87% | 0.27% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Common Stock | 169725 | $2.06 | 544,756.0000 | 5,101,459 | 23.76% | 3.33% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Common Stock | 282800 | $2.06 | 261,956.0000 | 5,101,459 | 51.91% | 5.54% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 1000000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 19.60% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 330000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 6.47% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 400000 | $0.31 | 0.0000 | 5,101,459 | 100.00% | 7.84% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 600000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 11.76% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 75000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 1.47% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 670000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 13.13% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 163000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 3.20% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 1056100 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 20.70% |
| Nov. 13, 2023 | Brunn Carsten | President and CEO | D | Employee Stock Option (right to buy) | 1275000 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 24.99% |
| Nov. 15, 2023 | SPRINGER TIMOTHY A | Director | A | Series A Convertible Preferred Stock | 24785 | $403.47 | 148,710.4880 | 5,101,459 | 20.00% | 0.49% |
| Nov. 15, 2023 | SPRINGER TIMOTHY A | Director | A | Series A Convertible Preferred Stock | 123925 | $403.47 | 148,710.4880 | 5,101,459 | 500.00% | 2.43% |
| Nov. 13, 2023 | SPRINGER TIMOTHY A | Director | D | Stock Option (Right to Buy) | 6410 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.13% |
| Nov. 13, 2023 | SPRINGER TIMOTHY A | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | SPRINGER TIMOTHY A | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | SPRINGER TIMOTHY A | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | SPRINGER TIMOTHY A | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | SPRINGER TIMOTHY A | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | SPRINGER TIMOTHY A | Director | D | Stock Option (Right to Buy) | 75000 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.47% |
| Nov. 13, 2023 | DeSilva Nishan M | Director | D | Stock Option (Right to Buy) | 80000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 1.57% |
| Nov. 13, 2023 | DeSilva Nishan M | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | DeSilva Nishan M | Director | D | Stock Option (Right to Buy) | 75000 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.47% |
| Nov. 13, 2023 | ZENNER PATRICK J | Director | D | Stock Option (Right to Buy) | 12820 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.25% |
| Nov. 13, 2023 | ZENNER PATRICK J | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | ZENNER PATRICK J | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | ZENNER PATRICK J | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | ZENNER PATRICK J | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | ZENNER PATRICK J | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | ZENNER PATRICK J | Director | D | Stock Option (Right to Buy) | 75000 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.47% |
| Nov. 13, 2023 | Davis Blaine | Chief Financial Officer | D | Employee Stock Option (right to buy) | 1250000 | $0.79 | 0.0000 | 5,101,459 | 100.00% | 24.50% |
| Nov. 13, 2023 | Myers Scott Dunseth | Director | D | Stock Option (Right to Buy) | 87500 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.72% |
| Sept. 25, 2023 | TRABER PETER G | Chief Medical Officer | S | Common Stock | 705 | $1.06 | 451,826.0000 | 5,101,459 | 0.16% | 0.01% |
| Sept. 25, 2023 | Brunn Carsten | President and CEO | S | Common Stock | 2932 | $1.06 | 783,081.0000 | 5,101,459 | 0.37% | 0.06% |
| May 31, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 26500 | $0.00 | 225,316.0000 | 5,101,459 | 10.52% | 0.52% |
| May 31, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 26500 | $0.00 | 251,816.0000 | 5,101,459 | 9.52% | 0.52% |
| May 30, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 43000 | $0.00 | 278,316.0000 | 5,101,459 | 13.38% | 0.84% |
| May 30, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 43000 | $0.00 | 321,316.0000 | 5,101,459 | 11.80% | 0.84% |
| Jan. 5, 2023 | Brunn Carsten | President and CEO | S | Common Stock | 77 | $1.12 | 786,013.0000 | 5,101,459 | 0.01% | 0.00% |
| Jan. 5, 2023 | Brunn Carsten | President and CEO | S | Common Stock | 13396 | $1.13 | 786,090.0000 | 5,101,459 | 1.68% | 0.26% |
| Jan. 4, 2023 | Brunn Carsten | President and CEO | S | Common Stock | 48 | $1.15 | 799,486.0000 | 5,101,459 | 0.01% | 0.00% |
| Jan. 4, 2023 | Brunn Carsten | President and CEO | S | Common Stock | 27549 | $1.13 | 799,534.0000 | 5,101,459 | 3.33% | 0.54% |
| Jan. 5, 2023 | TRABER PETER G | Chief Medical Officer | S | Common Stock | 20 | $1.11 | 446,121.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 5, 2023 | TRABER PETER G | Chief Medical Officer | S | Common Stock | 3445 | $1.13 | 446,141.0000 | 5,101,459 | 0.77% | 0.07% |
| Jan. 4, 2023 | TRABER PETER G | Chief Medical Officer | S | Common Stock | 15 | $1.14 | 449,586.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 4, 2023 | TRABER PETER G | Chief Medical Officer | S | Common Stock | 8164 | $1.13 | 449,601.0000 | 5,101,459 | 1.78% | 0.16% |
| Jan. 5, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 20 | $1.11 | 364,316.0000 | 5,101,459 | 0.01% | 0.00% |
| Jan. 4, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 11 | $1.15 | 367,708.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 5, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 3372 | $1.13 | 364,336.0000 | 5,101,459 | 0.92% | 0.07% |
| Jan. 4, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 6381 | $1.13 | 367,719.0000 | 5,101,459 | 1.71% | 0.13% |
| Jan. 5, 2023 | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 20 | $1.11 | 265,515.0000 | 5,101,459 | 0.01% | 0.00% |
| Jan. 5, 2023 | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 3372 | $1.13 | 265,535.0000 | 5,101,459 | 1.25% | 0.07% |
| Jan. 4, 2023 | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 11 | $1.14 | 268,907.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 4, 2023 | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 6381 | $1.13 | 268,918.0000 | 5,101,459 | 2.32% | 0.13% |
| Jan. 2, 2023 | Sallin Aymeric | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 5,101,459 | 9999.99% | 1.47% |
| Jan. 2, 2023 | TRABER PETER G | Chief Medical Officer | A | Employee Stock Option (right to buy) | 900000 | $0.00 | 900,000.0000 | 5,101,459 | 9999.99% | 17.64% |
| Jan. 2, 2023 | ZENNER PATRICK J | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 5,101,459 | 9999.99% | 1.47% |
| Jan. 2, 2023 | TRABER PETER G | Chief Medical Officer | A | Common Stock | 200000 | $0.00 | 457,765.0000 | 5,101,459 | 77.59% | 3.92% |
| Jan. 2, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | A | Common Stock | 100000 | $0.00 | 374,100.0000 | 5,101,459 | 36.48% | 1.96% |
| Jan. 2, 2023 | Johnston Lloyd P. | Chief Operations Officer | A | Employee Stock Option (right to buy) | 475000 | $0.00 | 475,000.0000 | 5,101,459 | 9999.99% | 9.31% |
| Jan. 2, 2023 | Johnston Lloyd P. | Chief Operations Officer | A | Common Stock | 100000 | $0.00 | 275,299.0000 | 5,101,459 | 57.05% | 1.96% |
| Jan. 2, 2023 | DeSilva Nishan M | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 5,101,459 | 9999.99% | 1.47% |
| Jan. 2, 2023 | COX CARRIE SMITH | Director | A | Stock Option (Right to Buy) | 107500 | $0.00 | 107,500.0000 | 5,101,459 | 9999.99% | 2.11% |
| Jan. 2, 2023 | Brunn Carsten | President and CEO | A | Employee Stock Option (right to buy) | 1275000 | $0.00 | 1,275,000.0000 | 5,101,459 | 9999.99% | 24.99% |
| Jan. 2, 2023 | Brunn Carsten | President and CEO | A | Common Stock | 282800 | $0.00 | 827,083.0000 | 5,101,459 | 51.96% | 5.54% |
| Jan. 2, 2023 | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 87500 | $0.00 | 87,500.0000 | 5,101,459 | 9999.99% | 1.72% |
| Jan. 2, 2023 | ANDO GORAN | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 5,101,459 | 9999.99% | 1.47% |
| Jan. 2, 2023 | Myers Scott Dunseth | Director | A | Stock Option (Right to Buy) | 87500 | $0.00 | 87,500.0000 | 5,101,459 | 9999.99% | 1.72% |
| Jan. 2, 2023 | Kishimoto Takashi Kei | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 475000 | $0.00 | 475,000.0000 | 5,101,459 | 9999.99% | 9.31% |
| Jan. 2, 2023 | SPRINGER TIMOTHY A | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 5,101,459 | 9999.99% | 1.47% |